DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20194615

Transient leukaemia of Down syndrome in a neonate: case report

Baraturam Bhaisara,, Charusheela Korday, Minal Wade, Chandra Kiran Chunchu, Priyanka Modi, Dinesh Kumar Singh

Abstract


Transient leukemia of Down syndrome(TL-DS)  or transient myeloproliferative disorder (TMD) or transient abnormal myelopoiesis (TAM) is a hematologic abnormality characterized by an uncontrolled proliferation of myeloblasts in peripheral blood and bone marrow which characteristically affects newborns and babies with Down syndrome. Children with Down syndrome (Trisomy 21) have a unique predisposition to develop myeloid leukemia of Down syndrome(ML-DS). In majority of cases of TL-DS, the GATA1 mutant clone goes into spontaneous remission without the need for chemotherapy. However, 10-20 % of neonates with TL-DS and silent TL-DS subsequently develop ML-DS in the first 5 years of life due to additional oncogenic mutations acquired by the persistent GATA1 mutant cells. We present here, one such case of Down syndrome with TL-DS in a neonate.

 


Keywords


Down syndrome, neonate, Transient abnormal myelopoiesis, Transient leukaemia of Down syndrome, Transient myeloproliferative disorder, Tumor lysis syndrome

Full Text:

PDF

References


Asim A, Kumar A, Muthuswamy S, Jain S, Agarwal S. Down syndrome: an insight of the disease. J Biomed Sci. 2015;22(1):41.

Swerdlow SH, editor. WHO classification of tumours of haematopoietic and lymphoid tissues. Internat Agency Resea Cancer; 2017.

Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, Taub JW, et al. A prospective study of the natural history of transient leukaemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood. 2006 Jun 15;107(12):4606-13.

Klusmann JH, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008 Mar 15;111(6):2991-8.

Muramatsu H, Kato K, Watanabe N, Matsumoto K, Nakamura T, Horikoshi Y, et al. Risk factors for early death in neonates with Down syndrome and transient leukaemia. British J Haematol. 2008 Aug;142(4):610-5.

Tunstall O, Bhatnagar N, James B, Norton A, O'Marcaigh AS, Watts T, et al. Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome. British J Haematol. 2018 Jul;182(2):200.

Bombery M, Vergilio JA. Transient abnormal myelopoiesis in neonates: GATA get the diagnosis. Archi Pathol Lab Med. 2014 Oct;138(10):1302-6.

Langebrake C, Creutzig U, Reinhardt D. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts. Klinische Pädiatrie. 2005;217(03):126-34.

Holt SE, Brown EJ, Zipursky A. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome. J Pediatric Hematol/Oncol. 2002 Jan 1;24(1):14-7.

Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I. Transient abnormal myelopoiesis and AML in Down syndrome: an update. Current hematologic malignancy reports. 2016 Oct 1;11(5):333-41.

Singh A, Mandal A, Guru V, Srinivasan S, Seth R. Transient abnormal myelopoiesis: a varied spectrum of clinical presentation. J Hematol. 2017 Mar 21;6(1):25-8.

Gamis AS, Alonzo TA, Gerbing RB, Hilden JM, Sorrell AD, Sharma M, et al. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. Blood. 2011 Dec 22;118(26):6752-9.

Jeha S. Tumor lysis syndrome. Seminars Hematol. 2001 Oct 1;(38):4-8.

Tragiannidis A, Pana ZD, Papageorgiou T, Hatzipantelis E, Hatzistilianou M, Athanassiadou F. Transient myeloproliferative disorder in a newborn with down syndrome treated with rasburicase for the risk of development of tumor lysis syndrome: A case report. J Med Case Reports. 2011 Dec;5(1):407.

Kato K, Matsui K, Hoshino M, Kawataki M, Ohyama M, Itani Y, et al. Tumor cell lysis syndrome resulting from transient abnormal myelopoiesis in a neonate with Down’s syndrome. Pediatr Internat. 2001 Feb 28;43(1):84-6.

Abe Y, Mizuno K, Horie H, Mizutani K, Okimoto Y. Transient abnormal myelopoiesis complicated by tumor lysis syndrome. Pediatr Internat. 2006 Oct;48(5):489-92.